Citarinostat
Citarinostat Uses, Dosage, Side Effects, Food Interaction and all others data.
Citarinostat is under investigation in clinical trial NCT02886065 (A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM).
Trade Name | Citarinostat |
Generic | Citarinostat |
Citarinostat Other Names | Citarinostat |
Type | |
Formula | C24H26ClN5O3 |
Weight | Average: 467.95 Monoisotopic: 467.1724174 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Citarinostat